Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 04-2025 | 01-2025 | 10-2024 | 07-2024 | 04-2024 | |
| Sales | 6,402 | 7,334 | 6,213 | 7,526 | 8,022 |
| Cost of Goods | 3,918 | 3,549 | 3,933 | 4,306 | 4,289 |
| Gross Profit | 2,484 | 3,785 | 2,280 | 3,220 | 3,733 |
| Operating Expenses | 6,791 | 5,936 | 6,835 | 6,187 | 6,065 |
| Operating Income | -3,389 | -1,602 | -3,622 | -2,661 | -2,043 |
| Other Income | 1,015 | 354 | 551 | 1,513 | -88 |
| Pre-tax Income | -2,374 | -1,248 | -3,071 | -1,148 | -2,131 |
| Net Income Continuous | -2,374 | -1,248 | -3,071 | -1,148 | -2,131 |
| Net Income Discontinuous | -416 | -287 | -305 | -12,233 | -889 |
| Net Income | $-2,790 | $-1,535 | $-3,376 | $-13,381 | $-3,020 |
| EPS Basic Total Ops | -0.05 | -0.03 | -0.07 | -0.26 | -0.06 |
| EPS Basic Continuous Ops | -0.04 | -0.02 | -0.07 | -0.02 | -0.04 |
| EPS Basic Discontinuous Ops | -0.01 | -0.01 | 0.00 | -0.24 | -0.02 |
| EPS Diluted Total Ops | -0.05 | -0.03 | -0.07 | -0.26 | -0.06 |
| EPS Diluted Continuous Ops | -0.04 | -0.02 | -0.07 | -0.02 | -0.04 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.01 | 0.00 | -0.24 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.02 | -0.05 | N/A | -0.03 |
| EBITDA(a) | $-3,071 | $-1,284 | $-3,303 | $-2,263 | $-1,706 |